Literature DB >> 35317269

Mechanisms of AMPA Receptor Inhibition by Diminazene.

A S Zhigulin1, M Yu Dron1, O I Barygin1.   

Abstract

Diminazene is an anti-infection agent for animals and is a member of the diarylamidine group. This study reports the first detection of its inhibitory effect on AMPA-type ionotropic glutamate receptors. Experiments were carried out on isolated Wistar rat neurons: striatal giant cholinergic interneurons were used to study calcium-permeable AMPA receptors and hippocampal field CA1 pyramidal neurons were used to study calcium-impermeable AMPA receptors. Cells were isolated by vibrodissociation and currents were recorded by voltage clamping in the whole cell configuration. Diminazene produced concentration-dependent inhibition of currents evoked by application of kainate in both neuron types. IC50 values for calcium-permeable and calcium-impermeable AMPA receptors were 60 ± 11 and 160 ± 30 μM, respectively. Of note is that the inhibitory action of diminazene increased with increases in agonist concentration. The plot of the voltage dependence of inhibition at a fixed diminazene concentration for calcium-permeable AMPA receptors was biphasic: minimal inhibition was seen at positive potentials and maximum at -40 to -60 mV, while further hyperpolarization produced a gradual decrease in blockade efficacy. All these properties provide evidence that diminazene blocks AMPA receptor channels, perhaps with penetration through channels into cells. © Springer Nature Switzerland AG 2022.

Entities:  

Keywords:  AMPA receptors; diminazene; inhibition mechanisms; patch clamp

Year:  2022        PMID: 35317269      PMCID: PMC8930484          DOI: 10.1007/s11055-022-01238-y

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  31 in total

1.  Voltage-dependent block of native AMPA receptor channels by dicationic compounds.

Authors:  D B Tikhonov; M V Samoilova; S L Buldakova; V E Gmiro; L G Magazanik
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

2.  Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy.

Authors:  Takahisa Hanada; Yutaka Hashizume; Naoki Tokuhara; Osamu Takenaka; Naohiro Kohmura; Aichi Ogasawara; Shinji Hatakeyama; Makoto Ohgoh; Masataka Ueno; Yukio Nishizawa
Journal:  Epilepsia       Date:  2011-06-02       Impact factor: 5.864

Review 3.  Targeting ionotropic receptors with polyamine-containing toxins.

Authors:  Ian R Mellor; Peter N R Usherwood
Journal:  Toxicon       Date:  2004-04       Impact factor: 3.033

4.  Design of antagonists for NMDA and AMPA receptors.

Authors:  K V Bolshakov; K H Kim; N N Potapjeva; V E Gmiro; D B Tikhonov; P N R Usherwood; I R Mellor; L G Magazanik
Journal:  Neuropharmacology       Date:  2005-08       Impact factor: 5.250

5.  GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses.

Authors:  S D Donevan; M A Rogawski
Journal:  Neuron       Date:  1993-01       Impact factor: 17.173

6.  Specific mechanism of use-dependent channel block of calcium-permeable AMPA receptors provides activity-dependent inhibition of glutamatergic neurotransmission.

Authors:  A V Zaitsev; K K Kim; I M Fedorova; N A Dorofeeva; L G Magazanik; D B Tikhonov
Journal:  J Physiol       Date:  2011-04-01       Impact factor: 5.182

7.  Mechanisms of NMDA receptor inhibition by diarylamidine compounds.

Authors:  Mikhail Y Dron; Arseniy S Zhigulin; Oleg I Barygin
Journal:  Eur J Neurosci       Date:  2019-11-01       Impact factor: 3.386

8.  Block of open channels of recombinant AMPA receptors and native AMPA/kainate receptors by adamantane derivatives.

Authors:  L G Magazanik; S L Buldakova; M V Samoilova; V E Gmiro; I R Mellor; P N Usherwood
Journal:  J Physiol       Date:  1997-12-15       Impact factor: 5.182

9.  Structure and synthesis of a potent glutamate receptor antagonist in wasp venom.

Authors:  A T Eldefrawi; M E Eldefrawi; K Konno; N A Mansour; K Nakanishi; E Oltz; P N Usherwood
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  Diminazene aceturate (Berenil) modulates the host cellular and inflammatory responses to Trypanosoma congolense infection.

Authors:  Shiby Kuriakose; Helen M Muleme; Chukwunonso Onyilagha; Rani Singh; Ping Jia; Jude E Uzonna
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.